Sign up to save your podcasts
Or
Share Creating Targeted Treatment Pathways Driven by Genomic Makeup & Cancer Type
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Creating Targeted Treatment Pathways Driven by Genomic Makeup & Cancer Type
Host: Paul P. Doghramji, MD, FAAFP
Guest: Edward S. Kim, MD
Thanks to recent research, we can now use a non-small cell cancer patient’s cancer type and genomic makeup to create targeted treatment plans. Joining Dr. Paul Doghramji to share what that approach looks like in practice is Dr. Edward Kim, the Chair of Solid Tumor Oncology and Investigational Therapeutics at the Levine Cancer Institute Atrium Health in Charlotte, North Carolina.
View all episodes
By ReachMDHost: Paul P. Doghramji, MD, FAAFP
Guest: Edward S. Kim, MD
Thanks to recent research, we can now use a non-small cell cancer patient’s cancer type and genomic makeup to create targeted treatment plans. Joining Dr. Paul Doghramji to share what that approach looks like in practice is Dr. Edward Kim, the Chair of Solid Tumor Oncology and Investigational Therapeutics at the Levine Cancer Institute Atrium Health in Charlotte, North Carolina.